ArticleNPJ science of food2025
Protective effects of Parabacteroides distasonis against high-fat diet-induced brain injury in mice.
Article in NPJ science of food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Gut Microbiota-Astrocyte Axis: New Insights into the Mechanisms of Comorbid Major Depressive Disorder in Type 2 Diabetes Mellitus.Molecular neurobiology · 2026Review
- Neuroprotective effects ofFrontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Recently, modulation of gut microbiota by probiotics treatment has emerged as a promising strategy for treatment of metabolic disorders. In this regarding, Parabacteroides distasonis (P. distasonis) has been shown to play a beneficial role in the treatment of different diseases and also been considered as potential probiotic, but nevertheless, its beneficial effect on central nervous system (CNS) disorders remains to be elucidated. In this study, we demonstrate that treatment with P. distasonis improves high-fat diet (HFD)-induced insulin resistance (IR) and decreases systemic oxidative stress. We further demonstrate that P. distasonis can alleviate HFD-induced brain barrier disruption and neuroinflammation, which was observed to be associated with increased HFD-induced systemic oxidative stress. Additionally, P. distasonis treatment significantly reversed HFD-induced abnormal proliferation and activation of astrocytes and microglia, and their interactions. The improved astrocyte-microglia networks may further contribute to inhibiting HFD-induced excessive synaptic pruning. Our findings suggest that P. distasonis plays a beneficial role in alleviating HFD-induced brain injury and provide possible explanations of how P. distasonis protects against HFD-induced brain injury, identifying the potential probiotic P. distasonis as a potential intervention in CNS disorders.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.